Get started
Author

Caner Kapar

Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study
2024 · Hasan Cagri Yildirim, Caner Kapar, et al. · Journal of Chemotherapy · 10
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study
2024 · Hasan Çağrı Yıldırım, Yasin Kutlu, et al. · International Journal of Clinical Oncology · 10
Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy
2024 · Ezgi Değerli, Çağatay Arslan, et al. · Medicina · 7
PDF
Evaluation of the Effects of Enzalutamide and Abiraterone Acetate on Sarcopenia in Metastatic Castration-Sensitive Prostate Cancer
2025 · Cevat İlteriş Kıkılı, Maide Müreva, et al. · Clinical Genitourinary Cancer · 4
Complete response with trastuzumab in heavily pretreated HER2-positive metastatic salivary duct carcinoma
2025 · Rumeysa Çolak, Caner Kapar, et al. · Anti-Cancer Drugs · 4
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma
2024 · Hasan Cagri Yildirim, Ertuğrul Bayram, et al. · Journal of Chemotherapy · 4
Very deep prostate-specific antigen decline is associated with longer rPFS in patients with metastatic castration-sensitive prostate cancer
2025 · Caner Kapar, Ilkay Gulturk, et al. · Therapeutic Advances in Medical Oncology · 3
Pathologic Response and Survival Outcomes on HER2-Low vs. HER2-Zero in Breast Cancer Receiving Neoadjuvant Chemotherapy
2025 · Rumeysa Colak, Caner Kapar, et al. · Medicina · 3
PDF
Nivolumab Efficacy and Safety in Cancer Patients with Renal Dysfunction
2024 · Ezgi Degerli, Mesut Yilmaz, et al. · Medical Bulletin of Haseki · 2
PDF
Could macrocytosis predict survival In advanced breast cancer patients that were treated with CDK 4–6 inhibitors?
2024 · Ilkay Gültürk, Rumeysa Colak, et al. · The Breast · 2
PDF
Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer
2024 · Rumeysa Çolak, Gökmen Umut Erdem, et al. · Asia-Pacific Journal of Clinical Oncology · 2
Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish Oncology Group Kidney Cancer Consortium (TKCC) Study
2026 · Murat Günaltılı, Hatice Bölek, et al. · Cancers · 1
Bone Pain Is Associated with Short Radiographic Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer
2026 · Aykut Özmen, Caner Kapar, et al. · Journal of Clinical Medicine · 1
The Clinical Significance of Gallium‐68 PSMA‐11 PET‐Derived SUVmax in the Management of Metastatic Hormone‐Sensitive Prostate Cancer
2026 · Cevat İlteriş Kıkılı, Caner Kapar, et al. · The Prostate · 1
Enhancing outcomes in mCRPC: the impact of androgen receptor inhibitor sequencing before 177Lu-PSMA-617 therapy
2025 · Satı Coşkun Yazgan, Kamil Kayaş, et al. · The Oncologist · 1
PDF
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program (EAP).
2025 · Deniz Tural, Oğuzcan Özkan, et al. · Journal of Clinical Oncology · 1
Insulin degludec/insulin aspart (IDegAsp) treatment on glycemic control and weight in patients with insulin experienced uncontrolled type 2 diabetes mellitus: A retrospective observational study
2025 · Ramazan Cakmak, Ozge Telci Caklili, et al. · Endocrine Regulations · 1
Assessment of Oral Capecitabine in Elderly Patients with Stage 2 Colon Cancer: Toxicity, Tolerability, and Survival Outcomes
2024 · Ezgi Değerli, İlkay Gültürk, et al. · Istanbul Medical Journal · 1
PDF
Efficacy and Safety of Ixabepilone in Metastatic Breast Cancer After Multiple Treatments: Analysis Based on Real-World Data
2024 · Goncagül AKDAĞ, Özkan ALAN, et al. · Journal of Oncological Sciences · 1
Prognostic value of CT-measured baseline tumor volume in nivolumab-treated metastatic renal cell carcinoma
2026 · Seher Yıldız Tacar, Deniz Tural, et al. · Tumori Journal
Author response for "Prognostic Value of CT Measured Baseline Tumor Volume in Nivolumab Treated Metastatic Renal Cell Carcinoma"
2026 · Seher Yıldız Tacar, Deniz Tural, et al. · Publons reviews and discussion
Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study
2026 · Fatih Kus, Fatih Atalah, et al. · BMC Cancer
Early Achievement of Ultra-low PSA Levels Correlates With Prolonged Radiologic Progression-free Survival (rPFS) in Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2026 · Deniz Tural, Fatih Kemik, et al. · Clinical Genitourinary Cancer
Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma
2026 · Caner Kapar, Oğuzcan Özkan, et al. · Immunotherapy
Prognostic impact of the Gustave Roussy Immune score in metastatic renal cell carcinoma treated with first-line immunotherapy-based combinations: results from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)
2026 · Aysun Fatma Akkuş, Hatice Bölek, et al. · BMC Cancer
Works count: 46
Citation count: 59
H-index: 4
I10-index: 2
Year
Topic
Type